QYResearch Reviewed: Global Mesenchymal Stem Cells Sales Market Report 2017
http://www.qyresearchglobal.com/goods-1248916.html Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal.
http://www.qyresearchglobal.com/goods-1248916.html
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>QYResearch</strong><br />
In the last several years, <strong>Global</strong> market of <strong>Mesenchymal</strong> <strong>Stem</strong> <strong>Cells</strong> developed rapidly, with<br />
an average growth rate of 6.2%. In 2015, <strong>Global</strong> revenue of <strong>Mesenchymal</strong> <strong>Stem</strong> <strong>Cells</strong> is about<br />
110 M USD.<br />
According to <strong>QYResearch</strong>, The global average gross margin of <strong>Mesenchymal</strong> <strong>Stem</strong> <strong>Cells</strong> is in<br />
the fluctuation trend, from 70% in 2012 to 67% in 2016. With the situation of global<br />
economy, gross margin will be in decreasing trend in the following five years.<br />
The type of <strong>Mesenchymal</strong> <strong>Stem</strong> <strong>Cells</strong> includes Human, Mouse, Rat. The proportion of Human<br />
in 2015 is about 39%, and the proportion of Mouse in 2016 is about 31%.<br />
<strong>Mesenchymal</strong> <strong>Stem</strong> <strong>Cells</strong> are widely sold in Research Institutes and Hospitals segment. The<br />
most proportion of <strong>Mesenchymal</strong> <strong>Stem</strong> <strong>Cells</strong> are sold in Research Institutes and the market<br />
share in 2016 is about 76%, but the Hospitals have upstream trend.<br />
www.qyresearch.com
Change language